Cargando…
Anti-Cancer Treatment Strategies in the Older Population: Time to Test More?
Aging is a well-recognized risk factor for the development of cancer. The incidence of new cancer diagnoses has increased globally given the rising senior population. Many hypotheses for this increased risk have been postulated over decades, including increased genetic and epigenetic mutations and t...
Autores principales: | Tralongo, Antonino C., Fratamico, Roberto S., Russo, Chiara, Sbrana, Andrea, Antonuzzo, Andrea, Danova, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167638/ https://www.ncbi.nlm.nih.gov/pubmed/33921136 http://dx.doi.org/10.3390/geriatrics6020042 |
Ejemplares similares
-
Older patients with cancer and febrile neutropenia in the COVID-19 era: A new concern
por: Tralongo, Antonino C., et al.
Publicado: (2020) -
Informed consent: time for more transparency
por: Yazici, Yusuf, et al.
Publicado: (2010) -
A “No More Waves” strategy for COVID-19 in Canada
por: Morris, Andrew M., et al.
Publicado: (2021) -
Immune checkpoint blockade with anti-programmed cell death 1 (PD-1) monoclonal antibody (mAb) cemiplimab: ongoing and future perspectives in rare genital cancers treatment
por: Gambale, Elisabetta, et al.
Publicado: (2022) -
Cell therapy for refractory angina: time for more ACTion
por: Psaltis, Peter J, et al.
Publicado: (2011)